The earnings call presented a mixed picture, with significant revenue growth in the Battery & Energy Products segment and successful integration of Electrochem being positive aspects. However, the decline in Communication Systems revenue, challenges with tariffs, and lower gross margins presented notable challenges. Despite these issues, ongoing product development and debt reduction efforts provide optimism for future growth.
Company Guidance -
Q3 2025
During the second quarter of 2025, Ultralife Corporation reported sales of $48.6 million, up from $43 million in the same period last year. The company's operating income stood at $2.3 million, which included a onetime $0.3 million adjustment, while net profit was $0.9 million, translating to $0.05 EPS on a GAAP basis and $0.07 on an adjusted basis. The company faced challenges including a 57.2% decline in Communications Systems segment revenue and a 20.4% decrease in commercial sales, particularly in medical battery sales and oil and gas, due to order timing and macroeconomic and geopolitical factors. The gross profit remained flat at $11.6 million, with a consolidated gross margin of 23.9%, down from 26.9% the previous year, impacted by product mix, tariffs, and lower factory throughput. Operating expenses rose by 22.2% to $9.3 million due to increased investment in new product development and costs related to the Electrochem acquisition. The total backlog of high-confidence orders was $89 million, with an adjusted EBITDA of $4.1 million or 8.5% of sales, down from $5.4 million or 12.6% the previous year. The company successfully repaid over $0.7 million of its acquisition debt in Q2, ahead of schedule, and reduced its debt principal by $3.4 million in the first half of 2025.
Revenue Growth in Battery & Energy Products
Revenues from the Battery & Energy Products segment were $45.9 million, compared to $36.7 million last year, driven by a 61.1% increase in government defense sales.
Successful Integration of Electrochem
Successfully transitioned Electrochem's ERP and office systems to Ultralife systems in Q2, completing the main system transition and planning further integration in Q3.
Debt Reduction Progress
Reduced acquisition debt by $3.4 million in the first half of 2025, exceeding the $2.8 million amortization required for the full year.
New Product Developments
Expanded the ruggedizer server case portfolio and developed a 20-Watt amplifier for international markets with expected orders later this year.
Ultralife (ULBI) Earnings, Revenues Date & History
The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
ULBI Earnings-Related Price Changes
Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Aug 07, 2025
$8.16
$6.77
-17.03%
May 09, 2025
$4.88
$5.05
+3.48%
Apr 01, 2025
$5.38
$5.05
-6.13%
Nov 08, 2024
$9.28
$7.98
-14.01%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Ultralife (ULBI) report earnings?
Ultralife (ULBI) is schdueled to report earning on Oct 23, 2025, Before Open (Confirmed).
What is Ultralife (ULBI) earnings time?
Ultralife (ULBI) earnings time is at Oct 23, 2025, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.